Remove 2010 Remove Access Remove Data
article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
article thumbnail

Akerna Releases 2021 Cannabis Industry Mid-Year Review

Cannabis Law Report

You can access the report here. Data Snapshot: Cannabis Consumer Spending and Trends: James Ahrendt , Business Intelligence Architect, Akerna. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and was the first cannabis software company listed on Nasdaq. About MJ Freeway.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Are Cannabis Users 22% More Likely to Need Emergency Care?

Veriheal

Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Pros and cons of any cannabis-related topic should be made easily accessible in relation to a study’s findings.

article thumbnail

New York: New Report Released Showing Ongoing Extreme Racial Disparities in Marijuana Enforcement at City and County Levels

NORML

Protecting youth – particularly young people of color, who continue to be disproportionately impacted – by both eliminating a common reason for introduction to the criminal justice system and preventing access to marijuana through a regulated market.

Marijuana 105
article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Johnson received the R.

article thumbnail

SC Labs Completes Rebrand of National Cannabis and Hemp Testing Network

Cannabis Law Report

“With hundreds of thousands of cannabis chemotypes analyzed, we’re able to deliver client data that provides insights and tools for chemometric classification and product development. SC Labs customers will gain benefits with access to the most comprehensive industry-forward testing solutions in North America. About SC Labs.

Hemp 52
article thumbnail

How Good Is Cannabis for Multiple Sclerosis (MS)?

Greencamp

Multiple sclerosis qualifies one for getting access to medical cannabis in some states in the US. In a 2010 study, MS patients were given Sativex (whole-plant formulation with 1:1 THC to CBD ratio), and placebo for 10 weeks. However, not all patients respond to these treatments well enough, and some don’t respond at all.